Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Plaque, Atherosclerotic
Interventions
DRUG

Clopidogrel

75mg once a day

DRUG

Ticagrelor

90mg twice a day

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

CHEOL WHAN LEE, M.D., Ph.D

OTHER